Literature DB >> 9301629

Deficiency of inflammatory cell adhesion molecules protects against atherosclerosis in mice.

M F Nageh1, E T Sandberg, K R Marotti, A H Lin, E P Melchior, D C Bullard, A L Beaudet.   

Abstract

Leukocyte and endothelial cell adhesion molecules (CAMs) are essential for emigration of leukocytes, with the selectins mediating the initial step of leukocyte "rolling" and the beta 2-(CD18) integrins and intercellular adhesion molecule-1 (ICAM-1) being important for firm adhesion and emigration. On the basis of evidence for an inflammatory component in the pathogenesis of atherosclerosis, including increased expression of CAMs, cytokines, and growth factors, we tested the hypothesis that decreased expression of inflammatory CAMs would reduce susceptibility to atherosclerosis. Using C57BL/6 mice fed a high-fat diet, we observed a 50% to 75% reduction in atherosclerotic fatty streaks in mice with homozygous mutations for ICAM-1, P-selectin, CD18, both ICAM-1 and CD18, or both ICAM-1 and P-selectin. In contrast to previous evidence of increased expression of CAMs in atherosclerotic lesions, which does not prove a cause-and-effect relationship, these data indicate directly that the level of expression of CAMs can determine the susceptibility to the formation of atherosclerotic fatty streaks. The results suggest that genetic variation at these loci could influence susceptibility to atherosclerosis and that pharmacological reduction of the expression or function of these CAMs might protect against atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9301629     DOI: 10.1161/01.atv.17.8.1517

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  74 in total

Review 1.  Genetics of atherosclerosis: the search for genes acting at the level of the vessel wall.

Authors:  V Villa-Colinayo; W Shi; J Araujo; A J Lusis
Journal:  Curr Atheroscler Rep       Date:  2000-09       Impact factor: 5.113

2.  VCAM-1 is critical in atherosclerosis.

Authors:  K Ley; Y Huo
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

Review 3.  Therapeutic strategies to deplete macrophages in atherosclerotic plaques.

Authors:  Inge De Meyer; Wim Martinet; Guido R Y De Meyer
Journal:  Br J Clin Pharmacol       Date:  2012-08       Impact factor: 4.335

4.  Elevated sICAM-1 levels in patients with hemorrhagic fever with renal syndrome caused by Hantaan virus.

Authors:  Qunying Han; Lei Zhang; Zhengwen Liu; Wen Kang; Sai Lou; Jianming Qiu; Zhu Li; Guoyu Zhang; Yawen Wang; Man Li; Na Li
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-08-21       Impact factor: 3.267

Review 5.  Atherosclerosis and the role of immune cells.

Authors:  Fulya Ilhan; Sevgi Tas Kalkanli
Journal:  World J Clin Cases       Date:  2015-04-16       Impact factor: 1.337

6.  The microcirculation: a motor for the systemic inflammatory response and large vessel disease induced by hypercholesterolaemia?

Authors:  Karen Y Stokes; D Neil Granger
Journal:  J Physiol       Date:  2004-12-20       Impact factor: 5.182

7.  P-Selectin and ICAM-1 synergy in mediating THP-1 monocyte adhesion in hemodynamic flow is length dependent.

Authors:  Erin Elizabeth Edwards; Susan Napier Thomas
Journal:  Integr Biol (Camb)       Date:  2017-04-18       Impact factor: 2.192

Review 8.  Myeloid cells in atherosclerosis: initiators and decision shapers.

Authors:  Oliver Soehnlein; Christian Weber
Journal:  Semin Immunopathol       Date:  2009-02-24       Impact factor: 9.623

Review 9.  Monocyte-endothelial cell interactions in the development of atherosclerosis.

Authors:  Javier Mestas; Klaus Ley
Journal:  Trends Cardiovasc Med       Date:  2008-08       Impact factor: 6.677

10.  Benzo[a]pyrene induces intercellular adhesion molecule-1 through a caveolae and aryl hydrocarbon receptor mediated pathway.

Authors:  Elizabeth Oesterling; Michal Toborek; Bernhard Hennig
Journal:  Toxicol Appl Pharmacol       Date:  2008-07-11       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.